Behavioral Cancer Management and Treatment – CCTD (90)
This panel reviews patient centered behavioral interventions aimed at managing and treating cancer, and its treatment-related symptoms to improve clinical recovery trajectories. Treatment approaches may include pharmacotherapies and other targeted therapies guided by cancer, type, stage, and patient’s health. Applications will also include studies of cancer-related treatment for cancer survivors. Applications may include (but are not limited to) technology-mediated approaches, early detection treatment practices, and adherence to cancer treatment regimens. Cancer treatment effects on the physical, psychological, social burden of cancer including for survivors of cancer and their families (e.g., mental health, social functioning, caregiver well-being and adaptation) are also included. All applications are in human populations. Applications proposing imaging and molecular biomarker approaches are not included. Applications proposing cellular, molecular, genetic, and physiological treatment approaches are not included. Applications proposing to increase access, use, reach, adoption, and implementation of cancer services are not included.
Review Dates
A roster for the panel will be posted here, at least 30 days prior to the review meeting
Topics
- Behavioral treatment approaches for acute and chronic symptoms and morbidities including those experienced by patients with metastatic cancer;
- Behavioral treatment approaches to improve cancer survivorship and improve physical health and function among survivors living with multiple chronic health conditions;
- Behavioral treatment strategies in specialty palliative care for patients with advanced cancer as well as the management of older adults undergoing cancer treatment;
